PMID- 28893082
OWN - NLM
STAT- MEDLINE
DCOM- 20190102
LR  - 20190102
IS  - 1940-1574 (Electronic)
IS  - 0003-3197 (Linking)
VI  - 69
IP  - 5
DP  - 2018 May
TI  - Relation Between TRCA Complication Rates and Peak ACT Levels Stratified According 
      to the BMI Tertiles.
PG  - 400-405
LID - 10.1177/0003319717729289 [doi]
AB  - We evaluated the efficacy and safety of the fixed dose of 5000 IU unfractionated 
      heparin (UFH) represented as peak activated clotting time (ACT) according to the 
      body mass index (BMI) tertiles in patients undergoing diagnostic transradial 
      coronary angiography (TRCA). A total of 422 patients were included in the present 
      study, 84 in the normal weight group, 218 in the overweight group, and the 120 in 
      the grades 1 and 2 obesity groups. Radial artery occlusion (RAO) was observed in 
      29 (6.8%) patients and the hematoma was observed in 43 (10.1%) patients. The rate 
      of RAO and hematoma did not differ across the BMI tertiles ( P = .749 and P = 
      .066). Also, peak ACT and procedure duration did not differ between the study 
      groups ( P = .703 and P = .999). The only independent predictor of hematoma was 
      sheath/radial artery diameter ( P = .011) and the independent predictors for RAO 
      were peak ACT, sheath/radial artery diameter, and procedure duration ( P = .001, 
      P = .028, and P < .001, respectively). In conclusion, a fixed dose of 5000 IU UFH 
      is safe and effective regardless of the BMI in diagnostic TRCA procedure.
FAU - Balci, Kevser Gulcihan
AU  - Balci KG
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Maden, Orhan
AU  - Maden O
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Balci, Mustafa Mucahit
AU  - Balci MM
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Cetin, Elif Hande
AU  - Cetin EH
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Kafes, Habibe
AU  - Kafes H
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Tola, Muharrem
AU  - Tola M
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Selcuk, Hatice
AU  - Selcuk H
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
FAU - Selcuk, Mehmet Timur
AU  - Selcuk MT
AD  - 1 Turkiye Yuksek Ihtisas Research and Education Hospital, Altindag, Ankara, 
      Turkey.
LA  - eng
PT  - Journal Article
DEP - 20170912
PL  - United States
TA  - Angiology
JT  - Angiology
JID - 0203706
RN  - 0 (Fibrinolytic Agents)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Arterial Occlusive Diseases/diagnosis/*etiology
MH  - Body Mass Index
MH  - Coronary Angiography/*adverse effects
MH  - Female
MH  - Fibrinolytic Agents/therapeutic use
MH  - Hematoma/diagnosis/*etiology
MH  - Heparin/therapeutic use
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity/*complications
MH  - *Radial Artery
MH  - Sensitivity and Specificity
MH  - *Whole Blood Coagulation Time
OTO - NOTNLM
OT  - activated clotting time
OT  - body mass index
OT  - complication
OT  - heparin
OT  - radial angiography
EDAT- 2017/09/13 06:00
MHDA- 2019/01/03 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2019/01/03 06:00 [medline]
PHST- 2017/09/13 06:00 [entrez]
AID - 10.1177/0003319717729289 [doi]
PST - ppublish
SO  - Angiology. 2018 May;69(5):400-405. doi: 10.1177/0003319717729289. Epub 2017 Sep 
      12.